FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRESCRIPTION DRUG USER FEE ACT AND BIOSIMILAR USER FEE AMENDMENTS HIRING AND RETENTION ASSESSMENT; PUBLIC MEETING; REQUEST FOR COMMENTS

WASHINGTON, Aug. 25 -- Food and Drug Administration has issued a notice called: Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment; Public Meeting; Request for Comments.

The notice was published in the Federal Register on Aug. 25 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment." The topic to be discussed is a hiring and retention assessment which was performed by an independent contractor.

For more information, contact Thamar Bailey, ...